GLI
VRTX icon

Guardian Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Guardian Life Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-757
Closed -$166K – 451
2019
Q4 		$166K Buy
757
+11
+1% +$2.23K 0.04% 117
2019
Q3 		$126K Buy
746
+9
+1% +$1.59K 0.02% 161
2019
Q2 		$135K Hold
737
– – 0.02% 145
2019
Q1 		$136K Buy
737
+17
+2% +$3.14K 0.02% 137
2018
Q4 		$119K Hold
720
– – 0.02% 140
2018
Q3 		$139K Buy
720
+20
+3% +$3.56K 0.02% 132
2018
Q2 		$119K Buy
700
+118
+20% +$18.3K 0.02% 146
2018
Q1 		$95K Sell
582
-234
-29% -$38.2K 0.02% 148
2017
Q4 		$122K Buy
816
+252
+45% +$37.3K 0.03% 163
2017
Q3 		$86K Buy
564
+7
+1% +$1.05K 0.01% 159
2017
Q2 		$72K Sell
557
-399
-42% -$48K 0.01% 174
2017
Q1 		$105K Buy
956
+6
+0.6% +$528 0.02% 200
2016
Q4 		$70K Buy
950
+26
+3% +$2.12K 0.01% 282
2016
Q3 		$81K Hold
924
– – 0.01% 277
2016
Q2 		$79K Buy
924
+15
+2% +$1.3K 0.01% 294
2016
Q1 		$72K Sell
909
-257
-22% -$23.2K 0.01% 303
2015
Q4 		$147K Sell
1,166
-257
-18% -$31K 0.01% 208
2015
Q3 		$148K Buy
1,423
+355
+33% +$45.6K 0.02% 234
2015
Q2 		$132K Buy
1,068
+10
+0.9% +$1.26K 0.01% 223
2015
Q1 		$125K Sell
1,058
-312
-23% -$37.4K 0.01% 242
2014
Q4 		$163K Buy
1,370
+16
+1% +$1.8K 0.02% 233
2014
Q3 		$152K Buy
1,354
+17
+1% +$1.62K 0.02% 233
2014
Q2 		$127K Buy
1,337
+24
+2% +$1.68K 0.01% 261
2014
Q1 		$93K Hold
1,313
– – 0.01% 327
2013
Q4 		$98K Buy
1,313
+642
+96% +$44.7K 0.01% 302
2013
Q3 		$51K Buy
+671
New +$53.4K ﹤0.01% 554

Other funds holding VRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Guardian Life Insurance's VRTX Position: Q1 2020 in Review

Guardian Life Insurance sold out of Vertex Pharmaceuticals (VRTX) in Q1 2020, closing a stake of 757 shares — an estimated $166K sold.

Guardian Life Insurance first reported a position in VRTX in Q3 2013 and held it in 26 quarters. The position peaked at $166K in Q4 2019. 854 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

  • Guardian Life Insurance reported no remaining Vertex Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 757 Vertex Pharmaceuticals shares in Q1 2020, an estimated $166K.
  • Guardian Life Insurance first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 26 quarters.
  • Guardian Life Insurance's Vertex Pharmaceuticals position peaked at $166K in Q4 2019.
  • 854 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.